Living Cell Technologies Ltd. (AU:1AI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Algorae Pharmaceuticals has successfully launched its AI platform, AlgoraeOS, which uses advanced neural networks to predict drug target synergies. In preclinical studies, their AI-116 drug candidate for dementia showed promising results, surpassing existing treatments. The company is also advancing trials for AI-168, targeting cardiovascular diseases, with results expected soon.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.